Next acquisition target for MIPS: DSP core?
(08/31/2007 1:41 PM EDT)

While keeping his cards close to the vest, MIPS CEO John Bourgoin hinted in an interview with EE Times this week that a DSP core company may be next.
With its acquisition of Chipidea Microelectronica, MIPS now owns not only processor cores—its bailiwick—but also analog and mixed-signal IP from Chipidea. All will be used to address the wireless, digital consumer and connectivity markets.
"MIPS should absolutely put a priority on developing complete MPU plus mixed signal subsystem IP products," said Gartner Group analyst Christian Heidarson. "If MIPS can shield mixed-signal integration issues from the SoC designer, this would be of tremendous value."
The deal brings MIPS more of the technology pieces it will need to become a supplier of virtual systems-on-chip, but the company has a ways to go yet.
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |
|
Related News
- Is Micron a Ripe Acquisition Target?
- What does Renesas' acquisition of PCB toolmaker Altium mean?
- Alphawave IP Acquires Optical DSP Chip Developer Banias Labs, Advancing its Optical DSP Products for Data Centers
- Synaptics to Acquire DSP Group, Expanding Leadership in Low Power AI Technology
- DSP Group Strengthens its Position in Rapidly Growing Headset Market with Acquisition of SoundChip SA
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design